Nakatani Y - Search Results

1

A crucial role of MafA as a novel therapeutic target for diabetes.

Kaneto H, Matsuoka TA, Nakatani Y, Miyatsuka T, Matsuhisa M, Hori M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. J Biol Chem. 2005 Apr 15;280(15):15047-52. doi: 10.1074/jbc.M412013200. Epub 2005 Jan 20. J Biol Chem. 2005. PMID: 15664997 Free article.

2

Modulation of the JNK pathway in liver affects insulin resistance status.

Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y, Hori M. Nakatani Y, et al. J Biol Chem. 2004 Oct 29;279(44):45803-9. doi: 10.1074/jbc.M406963200. Epub 2004 Aug 24. J Biol Chem. 2004. PMID: 15331609 Free article.

3

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.

Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, Hori M. Kaneto H, et al. Among authors: nakatani y. Nat Med. 2004 Oct;10(10):1128-32. doi: 10.1038/nm1111. Epub 2004 Sep 26. Nat Med. 2004. PMID: 15448687

4

Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.

Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, Ozawa K, Ogawa S, Hori M, Yamasaki Y, Matsuhisa M. Nakatani Y, et al. J Biol Chem. 2005 Jan 7;280(1):847-51. doi: 10.1074/jbc.M411860200. Epub 2004 Oct 27. J Biol Chem. 2005. PMID: 15509553 Free article.

5

Oxidative stress and the JNK pathway as a potential therapeutic target for diabetes.

Kaneto H, Kawamori D, Nakatani Y, Gorogawa S, Matsuoka TA. Kaneto H, et al. Among authors: nakatani y. Drug News Perspect. 2004 Sep;17(7):447-53. doi: 10.1358/dnp.2004.17.7.863704. Drug News Perspect. 2004. PMID: 15514704 Review.

6

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. J Mol Med (Berl). 2005 Jun;83(6):429-39. doi: 10.1007/s00109-005-0640-x. Epub 2005 Mar 10. J Mol Med (Berl). 2005. PMID: 15759102

7

PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance.

Kaneto H, Nakatani Y, Miyatsuka T, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. Diabetes. 2005 Apr;54(4):1009-22. doi: 10.2337/diabetes.54.4.1009. Diabetes. 2005. PMID: 15793239

8

The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation.

Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y. Kawamori D, et al. Among authors: nakatani y. J Biol Chem. 2006 Jan 13;281(2):1091-8. doi: 10.1074/jbc.M508510200. Epub 2005 Nov 9. J Biol Chem. 2006. PMID: 16282329 Free article.

9

Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.

Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. Int J Biochem Cell Biol. 2006;38(5-6):782-93. doi: 10.1016/j.biocel.2006.01.004. Int J Biochem Cell Biol. 2006. PMID: 16607699 Review.

10

Oxidative stress and the JNK pathway in diabetes.

Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Matsuhisa M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. Curr Diabetes Rev. 2005 Feb;1(1):65-72. doi: 10.2174/1573399052952613. Curr Diabetes Rev. 2005. PMID: 18220583 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,167 results

Search Page

Filters